Destiny Wealth Partners’s AstraZeneca AZN Stock Holding History

Destiny Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-524	Closed	-$103K	–	256
2026 Q1	$103K	Buy	+524	New	+$101K	0.01%	330
2023 Q1	–	Sell	-161	Closed	-$21.8K	–	217
2022 Q4	$21.8K	Sell	161 -251	-61%	-$31.5K	﹤0.01%	389
2022 Q3	$45K	Hold	412	–	–	0.01%	283
2022 Q2	$54K	Buy	+412	New	+$54.1K	0.01%	272
2021 Q4	–	Sell	-30	Closed	-$4K	–	543
2021 Q3	$4K	Buy	+30	New	+$3.49K	﹤0.01%	467
2021 Q1	–	Sell	-38	Closed	-$4K	–	542
2020 Q4	$4K	Buy	+38	New	+$4.03K	﹤0.01%	455

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Destiny Wealth Partners's AZN Position: Q2 2026 in Review

Destiny Wealth Partners sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 524 shares — an estimated $103K sold.

Destiny Wealth Partners first reported a position in AZN in Q4 2020 and held it in 6 quarters. The position peaked at $103K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Destiny Wealth Partners reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 524 AstraZeneca shares in Q2 2026, an estimated $103K.
Destiny Wealth Partners first reported a position in AstraZeneca in Q4 2020 and held it in 6 quarters.
Destiny Wealth Partners's AstraZeneca position peaked at $103K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.